These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant]. Morisot C, Simoens C, Trublin F, Lhermitte M, Gremillet C, Robert MH, Lequien P. Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252 [Abstract] [Full Text] [Related]
11. Acute hemodynamic effects of methylxanthine therapy in preterm neonates: Effect of variations in subgroups. M S, Nayak K, Lewis LES, Kamath A, Purkayastha J. J Trop Pediatr; 2019 Jun 01; 65(3):264-272. PubMed ID: 30085175 [Abstract] [Full Text] [Related]
15. [The choice between theophylline and caffeine in the treatment of apnea in premature infants]. Bairam A, Boutroy MJ, Badonnel Y, Vert P. Arch Fr Pediatr; 1990 Jun 01; 47(6):461-5. PubMed ID: 2206108 [Abstract] [Full Text] [Related]
16. Sequelae of caffeine treatment in preterm infants with apnea. Gunn TR, Metrakos K, Riley P, Willis D, Aranda JV. J Pediatr; 1979 Jan 01; 94(1):106-9. PubMed ID: 363996 [Abstract] [Full Text] [Related]
19. [Caffeine in the treatment of apnea in premature infants]. Aujard Y. Arch Fr Pediatr; 1990 Dec 01; 47(10):763. PubMed ID: 2082855 [No Abstract] [Full Text] [Related]
20. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study. Lista G, Fabbri L, Polackova R, Kiechl-Kohlendorfer U, Papagaroufalis K, Saenz P, Ferrari F, Lasagna G, Carnielli VP, Peyona® PASS Group. Neonatology; 2016 Dec 01; 109(3):221-7. PubMed ID: 26820884 [Abstract] [Full Text] [Related] Page: [Next] [New Search]